1. Home
  2. ADPT vs FBMS Comparison

ADPT vs FBMS Comparison

Compare ADPT & FBMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • FBMS
  • Stock Information
  • Founded
  • ADPT 2009
  • FBMS 1995
  • Country
  • ADPT United States
  • FBMS United States
  • Employees
  • ADPT N/A
  • FBMS N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • FBMS Major Banks
  • Sector
  • ADPT Health Care
  • FBMS Finance
  • Exchange
  • ADPT Nasdaq
  • FBMS Nasdaq
  • Market Cap
  • ADPT 1.2B
  • FBMS 1.2B
  • IPO Year
  • ADPT 2019
  • FBMS N/A
  • Fundamental
  • Price
  • ADPT $8.27
  • FBMS $36.35
  • Analyst Decision
  • ADPT Buy
  • FBMS Buy
  • Analyst Count
  • ADPT 5
  • FBMS 2
  • Target Price
  • ADPT $9.10
  • FBMS $45.00
  • AVG Volume (30 Days)
  • ADPT 1.4M
  • FBMS 140.0K
  • Earning Date
  • ADPT 02-11-2025
  • FBMS 01-28-2025
  • Dividend Yield
  • ADPT N/A
  • FBMS 2.76%
  • EPS Growth
  • ADPT N/A
  • FBMS 2.09
  • EPS
  • ADPT N/A
  • FBMS 2.44
  • Revenue
  • ADPT $178,957,000.00
  • FBMS $280,241,000.00
  • Revenue This Year
  • ADPT $20.07
  • FBMS N/A
  • Revenue Next Year
  • ADPT $25.27
  • FBMS $5.26
  • P/E Ratio
  • ADPT N/A
  • FBMS $15.02
  • Revenue Growth
  • ADPT 5.10
  • FBMS N/A
  • 52 Week Low
  • ADPT $2.28
  • FBMS $22.96
  • 52 Week High
  • ADPT $8.95
  • FBMS $39.21
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 58.94
  • FBMS 47.68
  • Support Level
  • ADPT $8.09
  • FBMS $36.30
  • Resistance Level
  • ADPT $8.69
  • FBMS $38.28
  • Average True Range (ATR)
  • ADPT 0.64
  • FBMS 0.81
  • MACD
  • ADPT -0.00
  • FBMS -0.23
  • Stochastic Oscillator
  • ADPT 65.66
  • FBMS 16.15

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About FBMS First Bancshares Inc.

First Bancshares Inc operates as a bank holding company. It offers various products and services such as deposit, including checking accounts, savings accounts, and time deposits account for individuals, businesses, associations and organizations, and governmental authorities. It also provides commercial and personal loans, including secured and unsecured loans, consumer loans, and loans for business expansion and purchase of equipment and machinery, and residential mortgage loans. The bank renders services like financial and wealth management, online internet banking, voice response telephone inquiry, safe deposit boxes, traveler's checks, and mobile deposit, and others. It operates in the Commercial/Retail Bank, Mortgage Banking, and Holding company segments.

Share on Social Networks: